NASDAQ: ZIVOZivo Bioscience Inc Stock
$2.72-0.03 (-1.09%)
Updated Jun 9, 2023
ZIVO Price
$2.72
Fair Value Price
$2.94
Market Cap
$25.62M
52 Week Low
$2.16
52 Week High
$4.60
P/E
-2.96x
P/B
-14.71x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$8.69M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
-1.65
Operating Cash Flow
-$6M
Beta
0.58
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
ZIVO Overview
ZIVO Bioscience, Inc., a research and development company, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. It operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. The company was formerly known as Health Enhancement Products, Inc. and changed its name to ZIVO Bioscience, Inc. in October 2014. ZIVO Bioscience, Inc. is based in Bloomfield Hills, Michigan.
Zen Score
–
Industry Average (27)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how ZIVO scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
ZIVO ($2.72) is undervalued by 7.51% relative to our estimate of its Fair Value price of $2.94 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
ZIVO ($2.72) is not significantly undervalued (7.51%) relative to our estimate of its Fair Value price of $2.94 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
ZIVO is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more ZIVO due diligence checks available for Premium users.
Be the first to know about important ZIVO news, forecast changes, insider trades & much more!
ZIVO News
Valuation
ZIVO fair value
Fair Value of ZIVO stock based on Discounted Cash Flow (DCF)
Price
$2.72
Fair Value
$2.94
Undervalued by
7.51%
ZIVO ($2.72) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
ZIVO ($2.72) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
ZIVO is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
ZIVO price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-2.96x
Industry
11.33x
Market
52.94x
ZIVO price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-14.71x
Industry
5.2x
ZIVO's financial health
Profit margin
Revenue
$0.0
Net Income
-$2.0M
Profit Margin
0%
ZIVO's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
Assets to liabilities
Assets
$1.1M
Liabilities
$2.9M
Debt to equity
-1.65
ZIVO's short-term liabilities ($2.79M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ZIVO's short-term assets ($928.21k) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ZIVO's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
ZIVO's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$2.1M
Investing
$0.0
Financing
$538.3k
ZIVO's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
ZIVO vs Biotech Stocks
Zivo Bioscience Stock FAQ
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.